BNF_10

This bulletin and associated resources support medicines optimisation in non neuropathic (non cancer) pain.  It looks at the place in therapy of different pain treatments and also helps identify where ...
Biosimilar Etanercept is the most recent biosimilar to become available within the NHS. This resource discusses the key issues for healthcare professionals considering a switch to biosimilar etanercept ...
The rubefacients bulletin supports the PrescQIPP DROP list. It reviews the place in therapy of the rubefacients which also have a nice do not do attached to them. An audit and patient letter are available ...
SPOT (Specials Prescribing Optimisation Tool) List now available to all PrescQIPP users. The SPOT-List is the first of our new specials documents that will form part of the specials webkit. It is a list ...
Created on 13 August 2015
These resources aim to provide clarity and guidance for prescribers and commissioners on biosimilars. Biological medicines have been with us for many decades. However it is only within the last ten years ...
Created on 22 June 2015
The NSAIDs bulletin and supporting resources look at the risks associated with long term treatment of NSAIDs and also appropriate choice of NSAID.  SystmOne and EMIS searches are available to support ...
Created on 14 May 2014
To ensure that the website is kept up to date and you are able to find the most recent and relevant bulletins with ease, we have now archived some of our older publications. These are still available ...
The PAC policy statement - PAC PS02 - Tocilizumab for rheumatoid arthritis was originally issued in June 2012. In July 2013, this underwent UKMi Review and has been restyled without amendment. ...